Feed OSUR
OS

OraSure Technologies, Inc. OSUR NASDAQ · Healthcare · United States

$3.62 +0.00% +$0.00

Market cap
$250.0M
Enterprise value
$113.4M
P/E
-
Forward P/E
-
PEG
-
P/S
2.2x
P/FCF
-
EV/EBITDA
-
ROIC
-14.7%
Gross margin
41.9%
Net margin
-41.7%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-
Beta
1.06
Free float
82.6%

About the company

OraSure Technologies, Inc. (OSUR) is a company focused on diagnostic solutions and testing in the healthcare sector. With over two decades of history, OraSure Technologies is a leading provider of technologies for non-invasive diagnostics and monitoring of infectious diseases and other health conditions. Their innovative products include rapid tests, genetic analyses, and laboratory diagnostics. The company is also engaged in combating the spread of diseases and supports health prevention and care. OraSure Technologies, Inc. (OSUR) shares could be suitable for investors who want to contribute to the development of advanced diagnostic technologies and the improvement of healthcare.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Carrie Eglinton Manner

Employees

500

Headquarters

Bethlehem

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

  • What to watch: Revenue fell by 33% a year over the last 3 years.
  • What to watch: It missed profit estimates 5 times in the last 8 quarters.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What to watch: The company made a loss over the last 12 months.

Financial health

Can it carry its debt?

  • What speaks for it: It holds more cash than debt: $148.2M against $11.6M.

Capital and dividends

What does the company do with the money it earns?

  • What speaks for it: It bought back its own shares for $15.0M in the last fiscal year, 6.0% of its market value.

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy